XKON/217950 (XKON/217950)

Korea New Exchange: XKON/217950 · KRW

₩29,200

-50.00 (-0.2%)· Recorded snapshot

Market cap	122.1B
Revenue (ttm)	178.2M
Net income (ttm)	-883.5M
EPS (ttm)	-₩22,088
Shares out	4.2M
Volume	24
Beta	0.39

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 178.2M
Net income (ttm): -883.5M
EPS (ttm): -₩22,088
Market cap: 122.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All XKON/217950 indicators

Market & fundamental data

Available fields

134

Groups with data

Currency

KRW

Showing 134 of 134 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Fiscal year end	December
Founded	2009
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	KR7217950005
Last refreshed	2026-10-28
Market cap	KRW 122.1B
Price	KRW 29,200.00
Price currency	KRW
SIC code	2834
Stock price date	2026-10-28
Symbol	xkon/217950
Website	https://pr-bio.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-75.64%
FCF yield	-0.34%
Industry P/E	26.13x
P/S ratio	685.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	90.55%
Operating margin	-426.37%
Pretax margin	-495.83%
ROCE	-162%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue growth	-44.52%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -29.1M
Depreciation and amortization	KRW 4.7M
EBIT	KRW -759.8M
EBITDA	KRW -755.1M
EPS	KRW -22,088.06
FCF per share	KRW -99.44
Financing cash flow	KRW -50.7M
Free cash flow	KRW -415.8M
Gross profit	KRW 161.4M
Investing cash flow	KRW -71.8M
Net borrowing	KRW -50.7M
Net cash flow	KRW -509.1M
Net income	KRW -883.5M
Operating income	KRW -759.8M
Revenue	KRW 178.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-6.67
Book value per share	KRW -21,104.73
Interest coverage	-6.18
Long-term assets	KRW 83.8M
Long-term liabilities	KRW 1.3B
Net cash (debt)	KRW -614.2M
Net cash / market cap	-0.5%
Piotroski F-Score	1
Property, plant and equipment	KRW 30.8M
Shareholders' equity	KRW -844.2M
Tangible book value	KRW -844.2M
Tangible book value per share	KRW -21,104.73
Total assets	KRW 515.5M
Total cash	KRW 429M
Total debt	KRW 1B
Total liabilities	KRW 1.4B
WACC	6.44%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	KRW 431.6M
Current liabilities	KRW 46.5M
Current ratio	9.28
Net working capital	KRW -27.4M
Quick ratio	9.23
Working capital	KRW 385.1M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	KRW 31,956.33
1D price change	-0.17%
1M price change	-1.68%
1M total return	-1.68%
1W price change	0.34%
1W total return	0.34%
1Y price change	-10.41%
1Y return CAGR	-10.42%
1Y total return	-10.41%
20-day SMA	KRW 29,210.00
200-day SMA	KRW 32,473.50
3M price change	-7.87%
3M total return	-7.87%
3Y price change	43.03%
3Y return CAGR	12.67%
3Y total return	43.03%
50-day SMA	KRW 30,147.00
50-day SMA vs 200-day SMA	50under200
52-week high	KRW 37,450.00
52-week high date	2026-01-30
52-week low	KRW 25,000.00
52-week low date	2025-12-12
5Y price change	-17.14%
5Y return CAGR	-3.69%
5Y total return	-17.14%
6M price change	-16.43%
6M total return	-16.43%
All-time high	KRW 50,000.00
All-time high date	2025-05-02
All-time low	KRW 6,170.00
All-time low date	2019-10-07
Average true range (ATR)	KRW 862.98
Average volume	252
Beta (1Y)	0.21
Beta (2Y)	0.12
Beta (5Y)	0.39
Change from 52-week high	-22.03%
Change from 52-week low	16.8%
Change from all-time high	-41.5%
Change from all-time low	374.07%
Change from open	-0.51%
Day's gap	0.34%
Dollar volume	KRW 700,800
High price	KRW 29,350.00
Low price	KRW 28,600.00
Monthly RSI	46.48
Open price	KRW 29,350.00
Position in 52-week range	80%
Previous close	KRW 29,250.00
Price vs 150-day SMA	-8.47%
Price vs 20-day SMA	0.14%
Price vs 200-day SMA	-9.93%
Price vs 50-day SMA	-2.98%
Relative volume	0.09
RSI	45.31
Sharpe ratio	-0.31
Sharpe ratio (3Y)	0.36
Sharpe ratio (5Y)	0.19
Sortino ratio	-0.3
Sortino ratio (3Y)	0.74
Sortino ratio (5Y)	0.42
Volume	24
Weekly RSI	39.15
YTD price change	-7.44%
YTD total return	-7.44%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.1M
Shares held by insiders	2.72%
Shares outstanding	4.2M

Deeper analysis on XKON/217950

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this XKON/217950 report

Is a complete XKON/217950 research report available?

No complete published report is available for xkon/217950 (XKON/217950) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

XKON/217950 (XKON/217950)

Price

Financial snapshot

Fair-value bridge

Latest news · XKON/217950

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XKON/217950 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on XKON/217950

Frequently asked questions